Jaguar Health, Inc. (JAGX) Financials

JAGX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 37.4 million 53.2 million
Dec. 31, 2025 38.3 million 57.0 million
Sept. 30, 2025 49.5 million 45.1 million
June 30, 2025 48.3 million 41.4 million

JAGX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 8.8 million 155000
Dec. 31, 2025 -5.5 million -1.4 million
Sept. 30, 2025 -4.7 million 135000
June 30, 2025 -6.2 million 279000

JAGX Net Income

No data available :(

JAGX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 7.3 million 11.1 million 1.2 million
Dec. 31, 2025 968000 15.1 million 1.1 million
Sept. 30, 2025 3.5 million 7.6 million 1.1 million
June 30, 2025 2.2 million 10.7 million 1.2 million

JAGX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 515788
Dec. 31, 2025 199329
Sept. 30, 2025 43234
June 30, 2025 28994

JAGX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 29000 3.9 million 5.0 million 896000
Dec. 31, 2025 29000 14.3 million 5.3 million 1.5 million
Sept. 30, 2025 54000 3.7 million 6.1 million 737000
June 30, 2025 - 3.3 million 7.2 million 1.0 million

JAGX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 20.3 million 1.2 million
Dec. 31, 2025 3.2 million 2.2 million
Sept. 30, 2025 3.1 million 532000
June 30, 2025 3.0 million 527000

JAGX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

JAGX

Price: $2.25

52 week price:
2.25
144.90

Payout Ratio Range:
-237.08%
-17.47%

Earnings Per Share: -801.20 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 617552

Ebitda: -16.5 million

Market Capitalization: 194589

Links: